Comparing Injection Methods for Cancer Treatment in Mice
Author Information
Author(s): Vasylyshyn Taras, Patsula Vitalii, Větvička David, Shapoval Oleksandr, Pankrác Jan, Kabešová Martina, Beneš Jiří, Horák Daniel
Primary Institution: Institute of Macromolecular Chemistry, Czech Academy of Sciences
Hypothesis
Does intraperitoneal administration of nanoparticles lead to better tumor targeting than intravenous administration in a pancreatic cancer model?
Conclusion
Intraperitoneal administration of nanoparticles significantly increased their accumulation in pancreatic tumors compared to intravenous administration.
Supporting Evidence
- Intraperitoneal administration led to over six times higher nanoparticle accumulation in tumors compared to intravenous administration.
- Nanoparticles were designed to improve targeting and imaging of pancreatic tumors.
- The study utilized an orthotopic mouse model to better mimic human pancreatic cancer.
Takeaway
When treating cancer in mice, giving medicine directly into the belly works better than giving it through a vein because it helps the medicine get to the tumor more effectively.
Methodology
Mice with pancreatic tumors were injected with nanoparticles either intraperitoneally or intravenously, and their tissue accumulation was measured.
Potential Biases
Potential bias in the selection of administration routes and measurement techniques.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
10 female C57Bl/6 mice, aged 10 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website